Dr. David J. Mulvihill, MD
- Medicare services, 2024
- 106
- Medicare patients, 2024
- 100
- Part D claims, 2024
- 19
- Publications
- 7
- MIPS score, 2024
- 93
- Practice address
- 99 Beauvoir Avenue, Summit, NJ 07901
- Practice phone
- Call (908) 522-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Mulvihill's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. David J. Mulvihill is a radiation oncologist in Summit, New Jersey
Dr. Mulvihill practices at Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System.
Dr. Mulvihill's NPI, 1417274143, was assigned on April 20, 2010. Dr. Mulvihill holds New Jersey license 25MA08746400.
- NPI
- 1417274143NPI Registry (opens in a new tab)
- NPI enumeration date
- April 20, 2010
- NPI status
- Active
- Practice phone
- (908) 522-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 45
- Medical school graduation
- 2007
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. David J. Mulvihill practices at Overlook Medical Center in Summit, New Jersey
Dr. Mulvihill's primary practice is Overlook Medical Center, at 99 Beauvoir Avenue, Summit, NJ 07901 in Union County. The practice phone is (908) 522-2000.
- Overlook Medical Center99 Beauvoir Avenue, Summit, NJ 07901 · Union CountyPhone(908) 522-2000
Source: Dmand AI Affiliation Data
Dr. David J. Mulvihill is affiliated with 2 sites of care and 1 medical group
Dr. Mulvihill's primary practice is Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System. The medical group on file is MD Anderson Cancer Center at Cooper. Dmand AI also links Dr. Mulvihill to 1 more skilled nursing facility, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. David J. Mulvihill's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mulvihill practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Overlook Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Atlantic Health System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. David J. Mulvihill is one of 145 radiation oncologists in New Jersey
Radiation oncology is Dr. Mulvihill's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mulvihill is licensed in New Jersey.
Specialties and state licenses
- Radiation oncology, New JerseyPrimary
Radiation oncologists near Dr. Mulvihill
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. David J. Mulvihill billed Medicare for 106 services in 2024
CMS data shows 106 Medicare services from Dr. Mulvihill across 2 procedure codes in 2024, for 100 Medicare patients. Medicare paid $7,712 for them.
Dr. Mulvihill's Medicare services by type, 2021 to 2024
- 2021
- 2024
- Imaging
- 2021: 8202024: 10687%
- Office and hospital visits
- 2021: 492024: 0100%
Where Dr. Mulvihill's Medicare services took place, 2024
- In an office4946%
- In a facility5754%
Dr. Mulvihill compared with the New Jersey median for radiation oncologists, 2024
- Dr. Mulvihill
- New Jersey median
- Medicare services
- 106vs 1,81394% below
- Medicare patients
- 100vs 21052% below
- Part D claims
- 30vs 4635% below
Medians across 135 radiation oncologists in New Jersey with Dmand AI profiles that report each measure.
Dr. Mulvihill's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mulvihill?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mulvihill and other radiation oncologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. David J. Mulvihill treated 100 Medicare patients in 2024, average age 74
CMS counts 100 Medicare patients who saw Dr. Mulvihill in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mulvihill's median patient age at 68, with 0% women.
Dr. Mulvihill's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Mulvihill's Medicare patients by sex, 2024
- Women5757%
- Men4343%
Chronic conditions among Dr. Mulvihill's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis49%
- Diabetes39%
- Anxiety35%
- COPD31%
- Ischemic heart disease31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mulvihill's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women0%
- Men100%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. David J. Mulvihill wrote 19 Medicare Part D claims in 2024
In 2024, Dr. Mulvihill wrote 19 Medicare Part D claims for 16 patients. 95% of them were for generic drugs. They cover 1 drug, with $266 in total drug cost. In 2020, CMS named 39 claims across 2 drugs.
Dr. Mulvihill's Part D claims by kind of drug, 2024
- Generic18 claims95%
- Brand-name and other1 claims5%
Dr. Mulvihill's most prescribed drugs by claims, 2021
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2021
- 2020
- 2021
- Claims for drugs CMS names
- 2020: 392021: 3023%
Drugs named by CMS: 1 in 2021, 2 in 2020.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. David J. Mulvihill scored 93 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Mulvihill for performance year 2024, reported as part of a group.
Dr. Mulvihill's MIPS scores, performance year 2024
- 93of 100Final score
- 93.6of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 74of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. David J. Mulvihill has 7 publications on record
Dmand AI links 7 papers to Dr. Mulvihill, published from 2014 to 2021. 2020 was the busiest year, with 2. Dr. Mulvihill's most frequent co-authors are Gregory Kubicek, MD, Alan R. Turtz, MD and Gary A. Eastwick, MD.
Dr. Mulvihill's papers by year, 2014 to 2021
Dr. Mulvihill's most frequent co-authors
- Gregory Kubicek, MD4 shared papers
- Alan R. Turtz, MD4 shared papers
- Gary A. Eastwick, MD2 shared papers
Recent publications by Dr. Mulvihill
Acad Radiol
See who Dr. Mulvihill researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mulvihill works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. David J. Mulvihill received $120 in industry payments from 2016 to 2024
CMS Open Payments shows 7 general payments to Dr. Mulvihill from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. INSYS Therapeutics Inc paid the most, $36.
General payments to Dr. Mulvihill by program year, 2016 to 2024
Companies that paid Dr. Mulvihill the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. David J. Mulvihill's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. David J. Mulvihill
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. David J. Mulvihill's NPI number?
Dr. David J. Mulvihill's NPI number is 1417274143. It was assigned on April 20, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. David J. Mulvihill?
Dr. David J. Mulvihill is a radiation oncologist in Summit, New Jersey. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. David J. Mulvihill practice?
Dr. Mulvihill practices at 99 Beauvoir Avenue, Summit, NJ 07901. Dr. Mulvihill's primary practice is Overlook Medical Center in Summit, New Jersey, part of Atlantic Health System. Dmand AI also links Dr. Mulvihill to 1 skilled nursing facility.
What is Dr. David J. Mulvihill's office phone number?
The practice phone on file for Dr. Mulvihill is (908) 522-2000.
What is Dr. David J. Mulvihill's medical license number?
Dr. Mulvihill holds New Jersey license 25MA08746400.
Which hospitals is Dr. David J. Mulvihill affiliated with?
Dr. Mulvihill practices at Overlook Medical Center in Summit, New Jersey.
What medical group is Dr. David J. Mulvihill part of?
Dr. Mulvihill is linked to MD Anderson Cancer Center at Cooper.
Does Dr. David J. Mulvihill accept Medicare?
Yes. CMS data shows Dr. Mulvihill billed Medicare for 106 services in 2024.
What is Dr. David J. Mulvihill's MIPS score?
Dr. Mulvihill's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.
How many Medicare patients does Dr. David J. Mulvihill see?
CMS counts 100 Medicare patients who saw Dr. Mulvihill in 2024, with an average age of 74.
Show 6 more questionsShow fewer questions
What services does Dr. David J. Mulvihill bill to Medicare?
In 2024, Dr. Mulvihill's most billed Medicare services were radiation oncology (77014) and radiation oncology (77427).
What drugs does Dr. David J. Mulvihill prescribe most?
In 2021 Medicare Part D data, Dr. Mulvihill's most prescribed drugs by claims were Tamsulosin HCl.
Has Dr. David J. Mulvihill received payments from drug or device companies?
CMS Open Payments shows $120 in general payments to Dr. Mulvihill from 5 companies from 2016 to 2024. The largest total came from INSYS Therapeutics Inc.
How long has Dr. David J. Mulvihill been practicing?
Dr. Mulvihill graduated from medical school in 2007, 19 years ago.
Does Dr. David J. Mulvihill do research?
Dmand AI links 7 publications to Dr. Mulvihill, published from 2014 to 2021.
Who does Dr. David J. Mulvihill publish with?
Dr. Mulvihill's most frequent co-authors are Gregory Kubicek, MD (4 shared papers), Alan R. Turtz, MD (4 shared papers) and Gary A. Eastwick, MD (2 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card